Erectile Dysfunction Drugs Market Share 2022: Global Trends, Key Players, Industry Analysis Report to 2028

The Erectile Dysfunction Drugs Market size is expected to grow at an annual average of 4% during 2021-2027. The increasing prevalence of erectile dysfunction is driving the global erectile dysfunction (ED) market. Erectile dysfunction can be caused by a variety of factors, including aging, cardiovascular disease, spinal cord injury, high blood pressure, and side effects of medications you take. Effective first-line treatments for ED include oral medications, such as oral phosphodiesterase type 5 (PDE5) inhibitors.

The following segmentation are covered in this report:

By Drug Type

• Sildenafil Citrate (Viagra)
• Vardenafil (Levitra/ Staxyn)
• Tadalafil (Cialis)
• Udenafil (Zydena)
• Lodenafil Carbonate (Helleva)
• Stendra/ Spedra (Avanafil)
• Mirodenafil (Mvix)
• Others

By Distribution Channel

• Hospital Pharmacies
• Retail Pharmacies
• Online Sales

Company Profile

• Eli Lilly and Co.
• Pfizer
• Bayer AG
• Dong-A Pharmaceutical Co. Ltd
• Vivus
• Meda Pharmaceuticals
• Apricus Biosciences
• Cristalia
• S.K. Chemicals Co
• Teva Pharmaceutical Industries Ltd
• Produtos Quimicos Farmaceuticos Ltd.
• Johnson & Johnson Services

Scope of the report

The research study analyses the Erectile Dysfunction Drugs Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:

Recent developments

• Market overview and growth analysis
• Import and export overview
• Volume analysis
• Current market trends and future outlook
• Market opportunistic and attractive investment segment

Geographic coverage

• North america market size and/or volume
• Latin america market size and/or volume
• Europe market size and/or volume
• Asia-pacific market size and/or volume
• Rest of the world market size and/or volume

Key Questions Answered by Erectile Dysfunction Drugs Market Report

• What was the Erectile Dysfunction Drugs Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
• What will be the CAGR of Market during the forecast period (2021-2027)?
• Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
• Which manufacturer/vendor/players in the Erectile Dysfunction Drugs Market was the market leader in 2020?
• Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.